Related Experiment Video

Updated: Apr 28, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

2.0K

Changes in platelet functional parameters and CD62 P expression in liver cirrhosis

G Xianghong1, C Guanping1, Y Fenghua1

  • 1Center Department of Clinical Laboratory Medicine, Linyi People's Hospital, Linyi 276003, China.

African Health Sciences
|June 19, 2014
PubMed

Insights

Platelet activation marker CD62P and mean platelet volume (MPV) increase, while blood platelet count (BPC) and platelet crit (PCT) decrease in liver cirrhosis patients. These platelet changes offer insights for clinical treatment and prognosis.

Area of Science:

  • Hematology
  • Hepatology
  • Clinical Biochemistry

Background:

  • Liver cirrhosis leads to hepatic impairment, portal hypertension, and multi-systemic damage.
  • Bleeding complications in liver cirrhosis are associated with alterations in platelet count (BPC), mean platelet volume (MPV), platelet crit (PCT), and CD62P expression.
  • Platelet indices like BPC and MPV can indirectly reflect CD62P expression levels.

Purpose of the Study:

  • To investigate alterations in platelet functional parameters and CD62P expression in liver cirrhosis.
  • To assess the potential of these platelet markers in guiding clinical treatments and prognoses for liver cirrhosis.

Main Methods:

  • CD62P expression was quantified using flow cytometry.
  • Peripheral blood BPC, MPV, and PCT were measured with an auto blood cell analyzer.
  • Statistical analysis was performed using SPSS 11.0.

Main Results:

  • Patients with liver cirrhosis exhibited significantly higher CD62P and MPV levels compared to healthy controls (P<0.01).
  • Conversely, BPC and PCT values were significantly lower in liver cirrhosis patients than in the control group (P<0.01).

Conclusions:

  • Liver cirrhosis is characterized by distinct changes in CD62P, BPC, MPV, and PCT.
  • Monitoring these platelet parameters, particularly CD62P, is valuable for understanding liver cirrhosis severity and for optimizing clinical treatment and patient prognosis.
Abstract

Keywords:
Liver cirrhosisexpressiongranula proteinplatelet parameters

More Related Videos

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

16.3K
A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

7.1K

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
34
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
380
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
26
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
6.9K